Journal of neuroradiology = Journal de neuroradiologie · 2026
CT-guided cyanoacrylate injection for spinal cerebrospinal fluid leaks in spontaneous intracranial hypotension: outcomes from an expanded cohort.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liao Liang, Harsan Oana, Puel Ulysse, Loukoul Wassim Abou, Zhu François, Balaazi Ahmed, Botta Fabio, Bracard Serge, Braun Marc, Anxionnat René
Аннотация
BACKGROUND: Definitive minimally invasive treatment of spontaneous intracranial hypotension (SIH) is challenging due to heterogeneous mechanisms and locations of spinal cerebrospinal fluid (CSF) leaks. We evaluated CT-guided percutaneous cyanoacrylate injection for spinal CSF leaks.
METHODS: We retrospectively reviewed consecutive SIH patients with CT myelography-confirmed leaks treated at our institution (2016-2025). Under local anesthesia, leak-type-tailored approaches were used: transforaminal or interlaminar for type 1 (dural tears) and posterior foraminal for types 2 (lateral leaks) and 3 (CSF-venous fistulas). Outcomes included HIT-6 and Bern scores (follow-up brain MRI only; post-treatment spine MRI not routinely performed). Paired t-tests compared baseline with primary follow-up (last post-cyanoacrylate assessment preceding any subsequent intervention).
RESULTS: Forty-four patients (mean age, 48.6 years, 25 women) underwent cyanoacrylate injection. Leak-type distribution: type 1 in 20/44 (45.5%), type 2 in 12/44 (27.3%), type 3 in 12/44 (27.3%). In total, 50 sites were treated; 5 patients (11.4%) had multiple sites addressed in one session. Mean procedure duration was 28.8 ± 6.5 minutes. No intraprocedural complications or neurologic deficits occurred. Transient (< 24 h) post-procedural locoregional pain occurred in 12/44 (27.3%). Mean follow-up was 16.3 ± 11.6 months. Mean HIT-6 decreased from 66.8 ± 2.9 to 40.0 ± 6.6 (p < 0.001), and Bern score from 7.2 ± 1.2 to 1.5 ± 1.5 (p < 0.001) on follow-up MRI (mean, 2.2 months). Favorable clinical outcomes occurred in 37/44 (84.1%): complete symptom resolution in 30 (68.2%) and subtotal in 7 (15.9%). Five (11.4%) with partial improvement underwent complementary posterior epidural blood patch at the index level and subsequently achieved favorable outcomes; 2/44 (4.5%) had no improvement and were referred for surgery.
CONCLUSION: These findings support CT-guided percutaneous cyanoacrylate as a versatile, effective, and safe therapy across SIH leak types, with high rates of favorable clinical outcomes and concordant brain imaging improvement. Future studies with standardized post-treatment spine imaging are needed to enable assessment of an anatomic closure endpoint, validate efficacy by leak type, and define this technique's role relative to other therapies.
METHODS: We retrospectively reviewed consecutive SIH patients with CT myelography-confirmed leaks treated at our institution (2016-2025). Under local anesthesia, leak-type-tailored approaches were used: transforaminal or interlaminar for type 1 (dural tears) and posterior foraminal for types 2 (lateral leaks) and 3 (CSF-venous fistulas). Outcomes included HIT-6 and Bern scores (follow-up brain MRI only; post-treatment spine MRI not routinely performed). Paired t-tests compared baseline with primary follow-up (last post-cyanoacrylate assessment preceding any subsequent intervention).
RESULTS: Forty-four patients (mean age, 48.6 years, 25 women) underwent cyanoacrylate injection. Leak-type distribution: type 1 in 20/44 (45.5%), type 2 in 12/44 (27.3%), type 3 in 12/44 (27.3%). In total, 50 sites were treated; 5 patients (11.4%) had multiple sites addressed in one session. Mean procedure duration was 28.8 ± 6.5 minutes. No intraprocedural complications or neurologic deficits occurred. Transient (< 24 h) post-procedural locoregional pain occurred in 12/44 (27.3%). Mean follow-up was 16.3 ± 11.6 months. Mean HIT-6 decreased from 66.8 ± 2.9 to 40.0 ± 6.6 (p < 0.001), and Bern score from 7.2 ± 1.2 to 1.5 ± 1.5 (p < 0.001) on follow-up MRI (mean, 2.2 months). Favorable clinical outcomes occurred in 37/44 (84.1%): complete symptom resolution in 30 (68.2%) and subtotal in 7 (15.9%). Five (11.4%) with partial improvement underwent complementary posterior epidural blood patch at the index level and subsequently achieved favorable outcomes; 2/44 (4.5%) had no improvement and were referred for surgery.
CONCLUSION: These findings support CT-guided percutaneous cyanoacrylate as a versatile, effective, and safe therapy across SIH leak types, with high rates of favorable clinical outcomes and concordant brain imaging improvement. Future studies with standardized post-treatment spine imaging are needed to enable assessment of an anatomic closure endpoint, validate efficacy by leak type, and define this technique's role relative to other therapies.